Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1992
A utilization and cost-benefit analysis of an aminoglycoside kinetics monitoring serviceJ Pinilla, S Shafran, J Conly
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 23, 2009
Improving access to care by allowing self-referral to a hepatitis C clinicK E Doucette, V Robson, S Shafran, et al.
Molecular Cancer Research : MCR|May 22, 2019
BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAKJordan S Shafran, Guillaume P Andrieu, Balázs Györffy, et al.
Prostate Cancer and Prostatic Diseases|July 22, 2020
BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancerJordan S Shafran, Naser Jafari, Allison N Casey, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|April 20, 2012
Prospective, randomized comparison of intravenous and oral ciprofloxacin with intravenous ceftazidime in the treatment of nosocomial pneumoniaR Saginur, G Garber, G Darling, et al.
Open Forum Infectious Diseases|February 27, 2018
Mycobacterium chimaera Infection After Aortic Valve Replacement Presenting With Aortic Dissection and PseudoaneurysmC R O'Neil, G Taylor, S Smith, et al.
Journal of Leukocyte Biology|March 2, 2018
BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironmentGuillaume P Andrieu, Jordan S Shafran, Jude T Deeney, et al.
Obesity Surgery|December 19, 2018
Revision of Roux-en-Y Gastric Bypass with Limb Distalization for Inadequate Weight Loss or Weight RegainReuben D Shin, Michael B Goldberg, Allison S Shafran, et al.
Cancer Letters|September 2, 2019
BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune responseGuillaume P Andrieu, Jordan S Shafran, Charlotte L Smith, et al.
The Prostate|April 11, 2022
Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteinsJoakin O Mori, Jordan S Shafran, Marija Stojanova, et al.
Pageof 2